Legal Representation
Attorney
Douglas R. Wolf
USPTO Deadlines
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 22, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 21, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Apr 3, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jul 21, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 4, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 19, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Oct 16, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 16, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Oct 16, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Oct 16, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 22, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 21, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Feb 21, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Feb 21, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 10, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 6, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 6, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 6, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 18, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 21, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 21, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 1, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 18, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 10, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 4, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 3, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations sold as a kit for use by pharmacists and physicians in creating compounded hormone replacement medicines, topical anti-inflammatory and ultrasound gels, pain and gastrointestinal disorders treatment medicines, and anti-inflammatory, antimicrobial, and antifungal treatment medicines; medicines for the treatment of cardiovascular diseases and disorders, colitis, muscle spasm, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; antibiotics; pharmaceutical products for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders having vancomycin, enalapril, lisinopril, and methotrexate as the active pharmaceutical ingredient; antacids; muscle relaxants; hormone replacement medicines; topical anti-inflammatory and ultrasound gels; pharmaceutical preparation for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; pharmaceuticals for use in the treatment of cancer and autoimmune diseases and disorders, and for the treatment and prevention of renal, oncological, inflammatory, gastrointestinal, gastroesophageal, and cardio-vascular diseases and disorders
First Use Anywhere:
20250100
First Use in Commerce:
20250100
Classification
International Classes
005